A key side effect to assess for in the patient receiving an IIb/IIIa inhibitor (i.e. Aggrastat, Integrilin or Reopro) IV drip while being transferred is:
a) Hypertension
b) Hypokalemia
c) Hypoglycemia
d) Hemorrhage